Mercer Global Advisors »

Heron Therapeutics shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $17k 13k 1.30
2025-09-30 $34k 27k 1.26
2019-12-31 $975k 42k 23.51
2019-09-30 $727k 39k 18.49
2019-06-30 $683k 37k 18.58
2019-03-31 $942k 39k 24.43

More positions owned by Mercer Global Advisors

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Msci Usa Mmentm (MTUM)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Apple (AAPL)
Dimensional Etf Trust Us High Profitab (DUHP)
Vanguard Charlotte Fds Total Int Bd Etf (BNDX)
Dimensional Etf Trust Intl Core Equity (DFIC)
Ishares Tr Msci Intl Moment (IMTM)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Internatnal Val (DFIV)
Dimensional Etf Trust Intl High Profit (DIHP)

View all positions for Mercer Global Advisors

Top funds holding Heron Therapeutics

Rubric Capital Management
Clearline Capital
Adage Capital Partners GP
BlackRock
Vanguard Group
Velan Capital Investment Management
Palisade Capital Management
Tang Capital Management
Tejara Capital
Baker Bros. Advisors
Geode Capital Management
State Street Corporation
JW Asset Management
D. E. Shaw & Co
Congress Park Capital

View all funds holding Heron Therapeutics